Alexander L. Satz
Senior Director DEL Strategy and Operations
Head of WuXi AppTec HitS Chemistry Department

Alex Satz has 15+ years experience building and leading DNA-encoded library (DEL) technology platforms, and is currently the senior director of DEL strategy and operations at WuXiAppTec. Prior to joining WuXiAppTec, Alex built and led the Roche DEL platform in Basel Switzerland and Nutley USA, and helped to develop the first industrial-scale DEL platform at Praecis Pharmaceuticals (later purchased by GlaxoSmithKline). Alex also worked as a medicinal chemist at AstraZeneca, was an NIH postdoctoral fellow at Harvard Medical School, and earned his PhD in organic chemistry from the University of California Santa Barbara. In the field of DEL, Alex has authored 18 peer-reviewed articles and two book chapters.

DEL like never before - 4th generation of DEL
2021-10-26
321 180 237 248
Simulated Screens of DNA Encoded Libraries: The Potential Influence of Chemical Synthesis Fidelity on Interpretation of Structure–Activity Relationships
ACS Comb. Sci., 2016, 18, 7, 415-424
Simulated screening of DNA encoded libraries indicates that the presence of truncated byproducts complicates the relationship between library member enrichment and equilibrium association constant (these truncates result from incomplete chemical reactions during library synthesis). Further, simulations indicate that some patterns observed in reported experimental data may result from the presence of truncated byproducts in the library mixture and not structure–activity relationships. Potential experimental methods of minimizing the presence of truncates are assessed via simulation; the relationship between enrichment and equilibrium association constant for libraries of differing purities is investigated. Data aggregation techniques are demonstrated that allow for more accurate analysis of screening results, in particular when the screened library contains significant quantities of truncates.
305 203 143 231
Analysis of the productivity of DNA encoded libraries
Med. Chem. Commun., 2016, 7, 1323-1331
DNA encoded library screens have gained recent interest as they allow for screening of millions of small molecules in a simple manner, with the goal of providing novel chemical starting points in target-based hit identification. Despite this interest, no publication describes the physical properties, novelty, or structural diversity of molecules derived from such screens, nor a comparison of productivity of different DNA encoded libraries. Here we address this gap by analysis of two DNA encoded library screens run against two protein targets employing mixtures of up to 16 different libraries. Fifty-seven exemplar small molecule compounds from 34 structurally distinct clusters were prioritized from the screening results, synthesized and tested for biochemical activity. Thirty-five of the 57 compounds possess significant biochemical activity (IC50 ≤ 10 μM). Seventeen of the 35 biochemically active compounds possess a molecular weight (MW) < 500 Dalton (Da) and clogP< 5, and 6 possess a MW < 400 Da and clogP< 4. None of the 57 DEL-derived compounds exist in the Roche corporate high throughput screening collection and public compound collections. Productivity per library was observed to be independent of library size. The most productive of the 16 investigated libraries was synthesized employing only simple chemistry. Physical properties of DEL-derived compounds correlate with average library properties when truncated sub-libraries are accounted for. Our analysis may help guide the design of future DNA encoded libraries.
232 191 218 162
DNA Compatible Multistep Synthesis and Applications to DNA Encoded Libraries
Bioconjugate Chem., 2015, 26, 8, 1623-1632
Complex mixtures of DNA encoded small molecules may be readily interrogated via high-throughput sequencing. These DNA encoded libraries (DELs) are commonly used to discover molecules that interact with pharmaceutically relevant proteins. The chemical diversity displayed by the library is key to successful discovery of potent, novel, and drug-like chemical matter. The small molecule moieties of DELs are generally synthesized though a multistep process, and each chemical step is accomplished while it is simultaneously attached to an encoding DNA oligomer. Hence, library chemical diversity is often limited to DNA compatible synthetic reactions. Herein, protocols for 24 reactions are provided that have been optimized for high-throughput production of DELs. These protocols detail the multistep synthesis of benzimidazoles, imidazolidinones, quinazolinones, isoindolinones, thiazoles, and imidazopyridines. Additionally, protocols are provided for a diverse range of useful chemical reactions including BOC deprotection (under pH neutral conditions), carbamylation, and Sonogashira coupling. Last, step-by-step protocols for synthesizing functionalized DELs from trichloronitropyrimidine and trichloropyrimidine scaffolds are detailed.
402 243 312 403
Ready to start your project at HitS?
DNA-Compatible Copper-Catalyzed
2021.8.15 likes 87
We report a DNA-compatible protocol for synthesizing amides from DNA-bound aldehydes and non-nucleophilic arylamines including aza-substituted anilines, 2-aminobenzimidazoles, and 3-aminopyrazoles.The reactions were carried out at room temperature and provided reasonable conversions and wide functional group compatibility.
Comment
Karl:
Very good idea, the author is a person who dares to practice and hopes to continue to work hard.
2021.08.15
Karl:
Very good idea, the author is a person who dares to practice and hopes to continue to work hard.
2021.08.15
Karl:
Very good idea, the author is a person who dares to practice and hopes to continue to work hard.
2021.08.15
WuXi AppTec HitS unit provides one-stop Target-to-Hit services that enable companies in the pharmaceuticals, biotech, and academics worldwide to seek premium drug discovery.
Contact Us
HitS_service@wuxiapptec.com
DEL_service@wuxiapptec.com
US: +1 (857) 500-0235
China: +86 (021) 2066-3521
Online inquiry
  • WuXi AppTec China
    240 Hedan Road, Shanghai 200131, China
    1318 Wuzhong Avenue, Suzhou 215104, China
  • WuXi AppTec US
    Suite 111, 22 Strathmore Road Natick
    MA 01760-2434, USA
  • Crelux GmbH, a WuXi AppTec Company
    Am Klopferspitz 19a
    82152 Martinsried, Germany
Copyright © 2020 WuXi AppTec, All Rights Reserved.